The latest news and developments related to extracorporeal CO2 removal and the Hemolung RAS.
This report describes a unique case of a difficult-to-ventilate patient with severe drug poisoning resulting in coma and aspiration pneumonia of the right lung. There was a large difference between the size and compliance of the right versus left lung due to a prior right lung transplant for underlying fibroelastosis, resulting in significant ventilation and perfusion mismatch. Low-flow ECCO2R with the Hemolung RAS was used successfully to enable both independent and ultra-protective lung ventilation.
Low-flow extracorporeal carbon dioxide removal is a minimally invasive alternative to intubation and mechanical ventilation when NIV alone is not enough. This new clinical approach is explored in a white paper from ALung’s clinical staff.
This new presentation explains the basics of extracorporeal carbon dioxide removal. The rationale for using ECCO2R in AE-COPD and ARDS is detailed with a review of the current clinical evidence.
The topic of ECCO2R will be featured in multiple sessions at the ISICEM meeting in Brussels. The major scientific session will take place on Tuesday, March 18th at 11:00 in the Silver Hall.
Get a full listing of all ISICEM ECLS programming here.
We invite you to learn more about Respiratory Dialysis with the Hemolung RAS at our booth (#1.35-1.36) located in the main exhibit hall.
Call for Abstracts and Publications
The body of evidence for ECCO2R continues to grow. We encourage you to submit your own experiences to medical meetings and journals for publication.
Upcoming abstract deadlines:
- EURO-ELSO (Paris): 17 March 2014
- ESICM (Barcelona): 17 April 2014